News Sentiment

ARQT sentiment intelligence

Arcutis Biotherapeutics Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 51 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Biotechnology Read-through group
Latest close 27.74 Week of 10 Jul 2026
Weighted tone 51/100

Balanced news tone

Market reaction Price moving ahead of tone

Price is moving more forcefully than the current news tone suggests.

Primary event Market update

83/100 classification confidence.

Company focus 39

directly relevant articles

Source quality 0

high-authority source matches

Trend context Trend inactive

+7.5% over one week, +13.8% over four weeks, trend inactive, and materially above fair value.

Latest direct headline Neutral

Arcutis to report Q2 2026 financial results on August 5

Market Reaction

Price moving ahead of tone

60/100 confidence

Price is moving more forcefully than the current news tone suggests.

Primary event Market update 83/100 classification
One-week reaction 7.5% Price confirming higher
Trend fit Trend inactive 13.8% over four weeks
Fair value 96.7% Materially above fair value

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 9
Neutral 35
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 39
Industry context 8
Sector context 0

Sources

Coverage mix

Publishers
Market source 11
Stock Titan 10
simplywall.st 7
GlobeNewswire 4
TradingView 3
MT Newswires 2
ChartMill 2
scanx.trade 1

Event Lens

What the news is about

Classified themes
Market update 29
Earnings 14
Guidance 2
Regulatory and legal 1
Analyst action 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47